Leo Pharma recalls Picato

Pharmaceutical

On strict precautionary measures, Leo Pharma has recalled its Picato (Ingenol Mebutate) stock, due to the concerns of potential hazards to skin malignancy. All healthcare professionals, that stock Picato, have been instructed to quarantine and return all remaining stock to the manufacturer.

“Leo Pharma has recalled its Picato stock, due to the concerns of potential hazards to skin malignancy.“
See all the latest jobs in Pharmaceutical
Return to news